Please select the eligibility criteria that correspond to the clinical trial below.
Title: Redesigning Medication Intensification Effectiveness Study for Diabetes
Brief Summary: The proposed research study aims to determine whether applying the University of Pittsburgh Medical Center Nurse-Directed Diabetes Management Protocols (NDMPs) leads to improved clinical outcome and process measures as recommended by American Diabetes Association (ADA), quality of life, treatment satisfaction and medication adherence for adults with diabetes, and favorable providers' satisfaction as compared to usual diabetes care. Furthermore, the cost-effectiveness of performing the NDMPs compared to usual diabetes care in primary care settings will also be assessed.


Options:
A: Inclusion Criteria:

* Diagnosis of diabetes and hypertension
* HgA1C value greater than or equal to 7.5
* Creatinine value less than or equal to 2.0mg/dl
* SBP greater than or equal to 140

Exclusion Criteria:

* Prior diagnoses of dementia using ICD-9 codes validated for a VA population
B: Inclusion Criteria:

* Convenience sample of 11 community health clinics (CHCs) that are members of OCHIN, Inc.

Exclusion Criteria:

* none, for study CHCs
C: Inclusion Criteria:

1. Age \>18 years
2. Diagnosis of type 1 or type 2 diabetes mellitus

   Any one of the following will be considered to be sufficient evidence that diabetes is present:
   * Current regular use of insulin for the treatment of diabetes
   * Current regular use of oral anti-hyperglycemia agents for the treatment of diabetes
   * Documented diabetes by American Diabetes Associate and/or World Health Organization criteria
3. Routine care follow-up is yearly or more frequent
4. English or Spanish speaking
5. Able and willing to provide informed consent
6. Willing to complete 24 months of study follow up

Exclusion Criteria:

1. Known HbA1c (patient report or available records at time of enrollment) \<7.5% within prior 6 months
2. Active participation in any type of intervention study
3. Initiation of insulin treatment within 3 months from date of enrollment
4. Prior complete panretinal photocoagulation or prior diabetes-related vitrectomy in both eyes
5. Advanced visual acuity loss in both eyes which prohibits ability to read study materials (tested as needed with reading test using materials in appropriate size script)
6. Significant renal disease including use of erythropoietin (Procrit, Epogen, Eprex) or a history of chronic renal failure requiring dialysis or kidney transplant
D: Inclusion Criteria:

1. Adults aged 18 or greater
2. The diagnosis of type 2 diabetes of the subjects should be 1 year or more prior to the inception of this study
3. Subjects will be on medication treatment for their type 2 diabetes
4. Subjects' A1C levels should be higher than 7% for study entry
5. LDLc\>100mg/d\*l or
6. Blood Pressure \>130/80\*mg/dl
7. Any combination of the #4, 5 \&6 At least one visit to the practice within the previous 12 months.

Exclusion Criteria:

1. Non-ambulatory
2. Gestational diabetes
3. Pregnant women (by self-report)
4. Subjects have received diabetes education services performed by the registered nurse from UPDI
5. Subjects are treated with exercise and diet only
6. Subjects are participating or will participate in other research studies
7. Subjects do not have insurance or cannot afford payments for diabetes care/treatment
8. Subjects are unable to read and comprehend English
9. Subjects are unable to provide informed consent
10. Other medical conditions for which these protocols are deemed inappropriate by the physician.

Answer: D